Please assess the completion status of the following clinical trial:

Trial Title: Zenith® p-Branch® Endovascular Graft Pivotal Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Pararenal or juxtarenal AAA ≥5.0 cm in diameter or 2 times the normal aortic diameter~* Pararenal or juxtarenal AAA with history of growth ≥0.5 cm/year~* Saccular aneurysm with aortic diameter greater than 1.5 times the normal aortic diameter that is deemed to be at risk for rupture based upon physician interpretation~Exclusion Criteria:~* Age \<18 years~* Life expectancy \<2 years~* Pregnant, breast-feeding, or planning on becoming pregnant within 60 months~* Inability or refusal to give informed consent by the patient or a legally authorized representative~* Unwilling or unable to comply with the follow-up schedule~* Simultaneously participating in another investigative device or drug study. (The patient must have completed the primary endpoint of any previous study at least 30 days prior to enrollment in this study.)~* Additional medical restrictions as specified in the Clinical Investigation Plan~* Additional anatomical restrictions as specified in the Clinical Investigation Plan

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Endovascular (Type: EXPERIMENTAL): Endovascular treatment using the Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents

Based on this trial design, predict the completion outcome and termination type (if applicable).